Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 35 - Antineoplastic agents
Patents for A61P 35 - Antineoplastic agents (221,099)
12/2008
12/18/2008WO2008152390A1 Thiazoliopyrimidines and their use as inhibitors of phosphatidylinositol-3 kinase
12/18/2008WO2008152387A1 Quinazoline derivatives as pi3 kinase inhibitors
12/18/2008WO2008152142A1 2 -aminoquinazoline derivatives and their therapeutic uses
12/18/2008WO2008152014A2 3-hetrocyclylidene-indolinone derivatives as inhibitors of specific cell cycle kinases
12/18/2008WO2008152013A1 Indolinone derivatives and their use in treating disease-states such as cancer
12/18/2008WO2008151833A2 Compounds for the modulation of huntingtin aggregation, methods and means for identifying such compounds
12/18/2008WO2008151637A2 Neuroplastin derived peptides
12/18/2008WO2008151558A1 Azaindole-indole coupled derivatives, preparation methods and uses thereof
12/18/2008WO2008151520A1 A use of sodium selenosulfate for supplementing selenium and enhancing the cure effectiveness of chemotherapy agents,and the rapidly preparing method thereof
12/18/2008WO2008151519A1 USE OF NARINGENIN AND NARINGIN AS INHIBITORS FOR TRANSFORMING GROWTH FACTOR-β1 SIGNALING PATHWAY
12/18/2008WO2008151437A1 Heme-oxygenase inhibitors and use of the same in the treatment of cancer and diseases of the central nervous system
12/18/2008WO2008151433A1 Injectable polymer-lipid blend for localized drug delivery
12/18/2008WO2008151428A1 Novel compositions for modulating mrna translation
12/18/2008WO2008131103A3 Drug discovery methods for aurora kinase inhibitors
12/18/2008WO2008131000A3 7-substituted indole mcl-1 inhibitors
12/18/2008WO2008130879A3 Tetrahydroindole and tetrahydroindazole derivatives
12/18/2008WO2008121467A3 Combination therapy for treating cancer
12/18/2008WO2008115974A3 Pyrazolopyrimidine analogs and their use as mtor kinase and pi3 kinase inhibitors
12/18/2008WO2008115259A3 Derivatives of benzoxadiazole suitable for the treatment of cell proliferative diseases
12/18/2008WO2008113756A3 Compounds having aryl-sulphonamidic structure useful as metalloproteases inhibitors
12/18/2008WO2008112695A3 Pyrazolo [3,4-d] pyrimidines and 1, 2, 5, 6-tetraaza- as- indacenes as protein kinase inhibitors for cancer treatment
12/18/2008WO2008109991A8 Inhibitors of carnitine palmitoyltransferase and treating cancer
12/18/2008WO2008109380B1 Nucleic acid compounds for inhibiting vegfr family gene expression and uses thereof
12/18/2008WO2008099071A3 Monoclonal antibody directed against the human ldl receptor
12/18/2008WO2008094942A3 Humanized antibodies against cxcr3
12/18/2008WO2008094575A3 1-h-pyrazolo(3,4b)pyrimidine derivatives and their use as modulators of mitotic kinases
12/18/2008WO2008080056A3 Pyridazinones and furan-containing compounds
12/18/2008WO2007092436A3 Compounds for treating inflammatory disorders, demyelinating disorders and cancers
12/18/2008US20080312426 Chicken leukemia inhibitory factor (LIF) and GNNE thereof
12/18/2008US20080312339 Fluorine-substituted alkyl phenol compounds and their uses
12/18/2008US20080312337 Anticancer Composition Comprising Obovatol or Obovatal
12/18/2008US20080312329 Nonpeptide Inhibitors of Matrix Metalloproteinases
12/18/2008US20080312328 Deuterium-enriched tamsulosin
12/18/2008US20080312325 Photochemotherapeutic method using 5-aminolevulinic acid and other precursors of endogenous porphyrins
12/18/2008US20080312317 12 membered-ring macrolactam derivatives
12/18/2008US20080312312 For treating prostate cancer; (6S,6aR,10aS)-2-Hydroxy-6-(4-hydroxy-phenyl)-6,6a,7,8,10,10a-hexahydro-benzo[c]chromen-9-one; testicular cancer, cardiovascular diseases, neurodegenerative disorders, urinary incontinence, central nervous system disorders, gastrointestinal tract disorders, osteoporosis
12/18/2008US20080312310 Compounds, Compositions and Methods
12/18/2008US20080312307 Mapk/erk kinase inhibitors
12/18/2008US20080312306 Polymorphs, solvates, and hydrate of 5-(4'-fluoro-2'-oxo-1',2'-dihydrospiro[cyclopropane-1,3'-indol]-5'-yl)-1-methyl-1h-pyrrole-2-carbonitrile
12/18/2008US20080312298 Methods for Identification of Modulators of Carm1 Methyl Transferase Activity
12/18/2008US20080312287 Compound and Methods For the Treatment of Cancer and Malaria
12/18/2008US20080312278 Hydroxyquinoline Derivatives
12/18/2008US20080312275 Novel Cyanoguanidine Compounds
12/18/2008US20080312273 Quinoline Derivatives Having Vegf Inhibiting Activity
12/18/2008US20080312270 Compounds and methods useful for treating asthma and allergic inflammation
12/18/2008US20080312267 Diagnosis and Treatment of Diseases Arising from Defects in the Tuberous Sclerosis Pathway
12/18/2008US20080312266 Steroidal Compounds For Inhibiting Steroid Sulphatase
12/18/2008US20080312265 Treatment of Drug-Resistant Tumors
12/18/2008US20080312260 Biological markers predictive of anti-cancer response to kinase inhibitors
12/18/2008US20080312259 SALTS OF THE JANUS KINASE INHIBITOR (R)-3-(4-(7H-PYRROLO[2,3-d]PYRIMIDIN-4-YL)-1H-PYRAZOL-1-YL)-3-CYCLOPENTYLPROPANENITRILE
12/18/2008US20080312258 METABOLITES OF THE JANUS KINASE INHIBITOR (R)-3-(4-(7H-PYRROLO[2,3-d]PYRIMIDIN-4-YL)-1H-PYRAZOL-1-YL)-3-CYCLOPENTYLPROPANENITRILE
12/18/2008US20080312252 Combination of Organic Compounds
12/18/2008US20080312251 Aminopyrimidine Compounds and Their Salts, Process for Preparation and Pharmaceutical Use Thereof
12/18/2008US20080312250 Combination Comprising a Bcrp Inhibitor and 4- (4-Methylpiperazin-1-Ylmethyl)-N-[4-Methyl-3- (4-Pyridin-3-Yl) Pyrimidin-2-Ylamino) Phenyl] -Benzamide
12/18/2008US20080312244 Squaric Acid Derivatives as Protein Kinase Inhibitors
12/18/2008US20080312238 4-Arylazo-3,5-Diamino-Pyrazole Compounds and Use Thereof
12/18/2008US20080312233 Therapeutic Morpholino-Substituted Compounds
12/18/2008US20080312228 Pyrimidine compound and medical use thereof
12/18/2008US20080312227 Substituted Pyrido(2,3-D) Pyrimidine Derivatives Useful as Medicines for the Treatment of Autoimmune Disorders
12/18/2008US20080312226 Amide Compound
12/18/2008US20080312225 Triazolophthalazines
12/18/2008US20080312224 Oxaphenanthrene Derivatives
12/18/2008US20080312223 Thiazole And Isothiazole Derivatives That Modulate The Activity Of CDK, GSK And Aurora Kinases
12/18/2008US20080312221 Quinoline derivative and quinazoline derivative inhibiting self-phosphorylation of hepatocytus proliferator receptor, and medicinal composition containing the same
12/18/2008US20080312219 Biologically active methylene blue derivatives
12/18/2008US20080312206 Chemical Compounds-149
12/18/2008US20080312202 6-substituted estradiol derivatives and methods of use
12/18/2008US20080312201 Reduced Toxicity Methotrexate Formulations and Methods for Using the Same
12/18/2008US20080312199 Treatments of therapy resistant diseases and drug combinations for treating the same
12/18/2008US20080312197 Pharmaceutical products containing hormones and a 25-hydroxy vitamin d compound
12/18/2008US20080312191 Novel Urokinase Inhibitors
12/18/2008US20080312185 SUBSTITUTED 3-AMINO-THIENO[2,3-b]PYRIDINE-2-CARBOXYLIC ACID AMIDE COMPOUNDS AND PROCESSES FOR PREPARING AND THEIR USES
12/18/2008US20080312178 Human G-Protein Receptor HGBER32
12/18/2008US20080312168 Novel Dispersible Tablet Composition
12/18/2008US20080312164 Isothiocyanates and glucosinolate compounds and anti-tumor compositions containing same
12/18/2008US20080312162 Methods and Compositions for Enzyme-Specific Activation of Carbohydrate-Conjugated Prodrugs
12/18/2008US20080312158 Semaphorin Gene Family
12/18/2008US20080312155 modified metastin containing aza-glycine, methyl arginine and N-acetyl tyrosine amino acids; cancer metastasis suppressing activity, a cancer growth suppressing activity
12/18/2008US20080312148 the protein is non-naturally occurring and has enhanced anti-viral and anti-proliferative activity in comparison to human interferon alpha 2b (HuIFN- alpha 2b)
12/18/2008US20080312141 Peptide ligands for prostate specific antigen
12/18/2008US20080312130 Drug delivery vehicle for cancer therapy, process for producing the same, and pharmaceutical preparation using the same
12/18/2008US20080311654 Effective as an anti-differentiator while the chicken differentiable cell is being cultured; enables stable supply of the LIF protein derived from chickens
12/18/2008US20080311608 Antagonist of the oncogenic activity of the protein MDM2, and use thereof in the treatment of cancers
12/18/2008US20080311223 Injectable polymer-lipid blend for localized drug delivery
12/18/2008US20080311189 Compositions Comprising Organometallic Molybdenum Compounds For Treating Cancer
12/18/2008US20080311183 Novel Inhibitors of Pyruvate Kinase as Therapeutic Agents for Cancer
12/18/2008US20080311156 Vaccines
12/18/2008US20080311145 Protein cage immunotherapeutics
12/18/2008US20080311144 Mutant forms of cholera holotoxin as an adjuvant
12/18/2008US20080311137 Carcinoembryonic Antigen Fusions and Uses Thereof
12/18/2008US20080311134 engineered by replacing one or more amino acids of a parent anti-MUC16 antibody with non cross-linked, reactive cysteine amino acids; Cys engineered anti-MUC16 antibodies (Ab) containing a heavy chain sequence, conjugated with one or more drug moieties through a linker; diagnostic and therapeutic uses
12/18/2008US20080311131 Human Mob-5 (IL-24) receptors and uses thereof
12/18/2008US20080311127 Combination therapy for treating disease
12/18/2008US20080311126 Antisense Oligonucleotides Directed to Ribonucleotide Reducatase R2 and Uses Thereof in Combination Therapies for the Treatment of Cancer
12/18/2008US20080311124 Nucleotide sequences coding tumor polypeptides for use in diagnosis, prevention and treatment of cell proliferative disorders
12/18/2008US20080311123 Compositions and methods for the therapy and diagnosis of breast cancer
12/18/2008US20080311121 Antibody antagonists of ve-cadherin without adverse effects on vascular permeability
12/18/2008US20080311118 Vascular endothelial cell growth factor antagonists and uses thereof
12/18/2008US20080311117 Antibodies against PD-1 and uses therefor
12/18/2008US20080311116 Process for the Determination of Inflammatory Process and Pharmaceutical Compositions for the Treatment Thereof
1 ... 880 881 882 883 884 885 886 887 888 889 890 891 892 893 894 895 896 897 898 899 900 ... 2211